admin
Patients recovered and discharged within12 Hours
India
healthysoch
New Delhi, June 09, 2021 :
The Monoclonal antibody successfully used in two patients with fast progression of symptoms within first seven days have changed the outcome. 36 year old healthcare worker with high grade fever, cough, myalgia, severe weakness and leucopenia was administered REGCov2 (CASIRIVIMAB Plus IMDEVIMAB) on day 6 of disease. Patient’s parameter improved within 12 hours and was discharged.
The second case was of R.K. Razdan, 80 year old male diabetic and hypertensive was presented with high grade fever, cough and toxic look. His oxygen saturation was more than 95% on room air. CT Scan confirmed mild disease. He was given REGCov2 on Day 5 of disease. Patient’s parameter improved with next 12 hours.
According to Dr. Pooja Khosla, Senior Consultant, Department of Medicine, Sir Ganga Ram Hospital, “Monoclonal antibody could prove to be a game changer in times to come if used at appropriate time. It can avoid hospitalization in high risk group and progression to severe disease. It can help escaping or reducing the usage of steroids and immunomodulation which would further reduce the risk of fatal infections like Mucormycosis, secondary bacterial and viral infections like CMV.
”Dr. Pooja added, “This awareness about early identification of high risk category in our population and timely therapy with Monoclonal antibody as day care treatment may reduce the burden of cost on healthcare sector
healthysoch
